Articles On Global Health (ASX:GLH)

S&P/ASX 200 rose 0.8% in February with Large Cap S&P/ASX 50 underperforming Midcap and Small Ordinaries Tech sector was the big winner up 19% in February as energy and materials sector slumped  Nyrada soars after preclinical study...

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Recce Pharmaceuticals (ASX:RCE) highlights ongoing initiatives within its Anti-Infective Research (AIR) Unit situated at the Murdoch Children’s Research Institute (MCRI), Victoria The collaboration has been crucial in delivering positive...

  ASX200 drops about 0.7pc on Wednesday Consumer Staples craters, as WOW CEO departs Small Caps led by diggers IXR, AW1 and the biopharma Alterity   The ASX200 has ended lower on Wednesday, tracking losses in New York as traders brace – a...

  Local markets ride commodities lift to offset weak performance from Wall Street on Friday ASX 200 benchmark finished the day on +0.09pc, a lot higher than it really had any right to Resources led the way, overcoming a significant deadwei...

  Melodiol subsidiary Mernova Medicinal continues to grow as a dominant player in lucrative Canadian cannabis market Product range expands into six Canadian provinces Further cost optimisation initiatives to remove $400k from Mernova annua...

  ASX200 dragged down by bad drugs The IT Sector is up 1.1pc, Healthcare is down about 3.2pc Small cap winners led by American Rare Earths and Appen   The benchmark was shot through the heart by CSL this morning leaving everything else in...

  Melodiol Global Health says 2023 been a milestone year with strong growth across portfolio Melodiol delivering on strategy to bring core operating subsidiaries into profitability Company says its strategic priority continues to be gener...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today. ICYMI Leaderb...

Melodiol subsidiary Health House International Australia delivers ~$1 million in revenue for October  Strong October performance continues progress from Q3 revenue of ~$3 million 12 month sales are ~$14 million, with EBITDA margin 12.7%...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Mernova Medicinal has achieved its highest ever monthly revenue of nearly $900k in October Company has already received more than $600k of product orders for November providing a bumper start to the quarter ME1 reports ~$7.5 million in u...

The S&P ASX 200 fell -3.8% in October with mid-caps falling -6.94% and small-caps down -5.45% for the month S&P ASX 200 Energy was the only sector that closed October in the black with all Australian equity factors in red Dimerix...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by...

Benchmark ASX index closes ahead +0.19% Materials lead ASX sectors on Tuesday Small caps led by ERW, NMR   Local markets have struggled to hang onto early gains after a mixed run on Wall Street overnight. The benchmark ASX200 (XJO) index...

Creso Pharma has changed its name to Melodiol Global Health (ASX:MEI) The cannabis-focused healthcare stock has seen a Canadian subsidiary post a 104 per cent increase in revenue vs Q3 CY22 The company reports it’s establishing a dom...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

On Monday, the Australian stock market experienced a decline as investors sought refuge in bonds and gold due to growing concerns about increasing tensions in the Middle East. At the closing bell, the S&P/ASX 200 was 0.35 per cent lower...

Global Health announces deal with Fujitsu Australia Althea raises $5.32m in sale and leaseback deal Immutep to present data from TACTI-002 in key international forum   Global Health signs with Fujitsu Global Health (ASX:GLH), a provider o...

Oil prices remained stable as Israel had not yet initiated its expected ground offensive in Gaza, while the United States intensified diplomatic efforts to prevent the crisis from escalating regionally. Brent crude traded near $91 per barre...

16 Oct 2023 - A snapshot of the stocks on the move, featuring Tamboran Resources (ASX:TBN), Melodiol Global Health (ASX:ME1, FRA:1X8) and Superior Resources (ASX:SPQ).

  Tamboran Resources (ASX:TBN) announced that an operational update, in which the A3H well was drilled in record time of less than 18 days. In response, Managing Director and CEO, Joel Riddle, said, “the A3H well was drilled and cemented at...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, that made announcements today.   ICYMI Leade...

Melodiol Global Health (ASX:ME1) has announced that its wholly-owned psychedelics subsidiary, Halucenex Life Sciences, has achieved encouraging preliminary results in the first five patients taking part in the phase 2 clinical trial...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today. ICYMI Leader...

Record sales drives Mernova to deliver third consecutive quarter of revenue growth Sales up 20% on Q2 FY23 and 104% on pcp with Mernova YTD revenue of more than $4.95 million Mernova continues to build dominant footprint across Canada, wh...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Molodiol business Mernova achieves record sales for Q3 2023 Highest-ever weekly sales in Nova Scotia and $740,022 in purchase orders booked in for Q4 already Management pursuing a number of initiatives to replicate the growth in Nova Scoti...

WASHINGTON, Sept. 20, 2023 /PRNewswire/ -- Seventeen patient advocacy organizations from North and South America, Europe, Asia and the Middle East have formed the Global Patient Alliance for Kidney Health. The Alliance aims to elevate pa...

Interim results of operational research in LIFT-TB countries support decision to roll out improved treatment PRETORIA, South Africa, Sept. 19, 2023 /PRNewswire/ -- Kyrgyzstan, Ukraine, and Uzbekistan — participants in the LIFT-TB project —...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Mernova secures first cannabis purchase order from Alberta Q3 revenues already breaking records with room for further growth Performance lays groundwork for strong second half in 2023   Melodiol Global Health (ASX:ME1) wholly-owned Canadi...

  ASX 200 find 0.5% to start the week, LTR looks ready to sell Energy stocks and miners offset IT and Consumer Discretionary losses Small cap winners led by EMD and GLH   Local markets were led higher on Monday, supported by resource busi...

Stockhead’s Top 10 at 11-ish, published once I’ve consumed enough coffee each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live (not frozen!) data. It’s a short, sharp update to help frame the tr...

Melodial Global Health welcomes moves to reschedule marijuana to a lower risk category in US Analyst says potential US policy change “could catalyse a significant re-rating of cannabis stocks” Melodial monitoring situation closely in even...

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Melodial’s subsidiary Mernova looks to achieve significant quarter-on-quarter growth in Q3 Mernova also continues to advance compliance pathway for GMP certification Mernova continues to build its presence in Canada, which legalised cannab...

1st Group jumps 22pc after purchase order for its virtual healthcare system Austco Healthcare wins a $2.6m contract in Singapore Invex Therapeutic to shut down clinical trial immediately   Million dollar+ contracts for 1ST Group and Austc...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

The benchmark has sagged to -0.24% to close out the week with a world-weary sigh. Falling crude prices hobbled the Energy sector, dragging it 1.93% lower. Small caps winner Rubix Resources is feeling some neighbourly love, thanks to Allk...

Formerly Creso Pharma, Melodiol Global Health has a new name and a fresh drive to supply best-in-class psychedelic and cannabis products as it pursues growth in global markets. And the company is certainly chasing global growth, closing in...

A late surge from InfoTech pushed the benchmark to close at +0.07% InfoTech out front on +1.75%, ahead of Energy and Consumer Discretionary Huge news from Azure helped neighbour Errawarra into top spot for Small Caps   It’s the end of the...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...